• OncoMed Pharmaceuticals, Inc. IPO Seeks to Raise Up to $115M More...
• JumpStart to Create 40 More Top Quality Jobs for Scientific and Business Talent More...
• Maxygen, Inc. (MAXY) Gets $30 Million Payment From Bayer HealthCare (BAY) More...
• Syngenta AG (SYT) and Devgen NV Enter Insect Control Research Partnership More...
• INC Research, Inc. Selects TransPerfect Trial Interactive's Trial Interactive Technology as its Electronic Trial Master File (eTMF) Solution More...
• Provectus Pharmaceuticals Inc. Forms Independent Board to Meet Corporate Governance Requirements More...
• Sinovac Biotech Ltd. (SNVBF) Names Danny Chung Chief Financial Officer More...
• Synthetic Biologics, Inc. (AEN) Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs More...
• Acurian, Inc. Reports Record First Quarter as a Result of Growing Demand for Its Patient Enrollment, Retention and Oncology Services More...
• BioLife Solutions, Inc. (BLFS.OB) Announces 7th Consecutive Quarter of Record Revenue More...
• Echo Therapeutics Announces First Quarter 2012 Financial Results More...
• Galectin Therapeutics Reports First Quarter 2012 Financial Results More...
• Genta Incorporated (GETA.OB) Reports First Quarter 2012 Financial Results More...
• Servier on Trial Over Diabetes-Diet Pill More...
• Helicos BioSciences Corporation (HLCS) Settles its Patent Litigation Against Pacific Biosciences More...
• Genomatica, Inc. Announces Successful Litigation Defense More...
• Synchrogenix Opens in Sweden More...
• Roche (RHHBY) Bets on Alzheimer's Drug More...
• FDA Says Unsure if Novartis AG (NVS) MS Pill Caused Deaths More...
• Stiefel Laboratories Receives FDA Approval of Fabior™ Foam, 0.1% More...
• Gilead Sciences, Inc. (GILD)' HIV Quad Pill Wins Backing From FDA Advisers More...
• Biovest International, Inc. to Seek Marketing Approval in the EU for BiovaxID® Personalized Lymphoma Cancer Vaccine More...
• Ventrus Biosciences, Inc. (VTUS) Unveils Positive Results of Its Phase 3 Trial of Diltiazem More...
• Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Phase III Crohn's Disease Trial Meets Primary Endpoints More...
• BioAlliance Pharma: Initiation of ReLive, Phase III Clinical Trial with Livatag® in Primary Liver Cancer More...
• Schwabing Hospital Release: New Phase III Study Confirms: Ginkgo Biloba Special Extract EGb 761® Significantly Improves Cognition and Neuropsychiatric Symptoms in Cognitive Disorders More...
• Eli Lilly and Company (LLY) Oncology to Highlight Final Results for Phase III Study in Most Common Form of Lung Cancer More...
• American Society of Clinical Oncology Preview: Eight Cancer Drugs to Watch at the Big Show More...
• Red Wine Compound Can Combat Alzheimer's, Georgetown University Medical Center Study More...
• High-Fat Diet Lowered Blood Sugar and Improved Blood Lipids in Diabetics,Linköping University Study More...
• Blood Pressure Drugs Don't Protect Against Colorectal Cancer, Cancer Reveals More...
• BG Medicine Announces Publication of First Study on Use of Galectin-3 in Selection of Drug Therapy in Heart Failure More...
• Agenix Limited: New Patent Granted in Japan Enhances Value of Revolutionary New Australian Blood Clot Diagnostic Technology More...
• Helicos BioSciences Corporation (HLCS) Settles its Patent Litigation Against Pacific Biosciences More...
• Biogen Idec, Inc. (Massachusetts) (BIIB)'s New AVONEX® Dosing Innovations for People with Multiple Sclerosis Now Available in US More...
• JumpStart to Create 40 More Top Quality Jobs for Scientific and Business Talent More...
• Maxygen, Inc. (MAXY) Gets $30 Million Payment From Bayer HealthCare (BAY) More...
• Syngenta AG (SYT) and Devgen NV Enter Insect Control Research Partnership More...
• INC Research, Inc. Selects TransPerfect Trial Interactive's Trial Interactive Technology as its Electronic Trial Master File (eTMF) Solution More...
• Provectus Pharmaceuticals Inc. Forms Independent Board to Meet Corporate Governance Requirements More...
• Sinovac Biotech Ltd. (SNVBF) Names Danny Chung Chief Financial Officer More...
• Synthetic Biologics, Inc. (AEN) Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs More...
• Acurian, Inc. Reports Record First Quarter as a Result of Growing Demand for Its Patient Enrollment, Retention and Oncology Services More...
• BioLife Solutions, Inc. (BLFS.OB) Announces 7th Consecutive Quarter of Record Revenue More...
• Echo Therapeutics Announces First Quarter 2012 Financial Results More...
• Galectin Therapeutics Reports First Quarter 2012 Financial Results More...
• Genta Incorporated (GETA.OB) Reports First Quarter 2012 Financial Results More...
• Servier on Trial Over Diabetes-Diet Pill More...
• Helicos BioSciences Corporation (HLCS) Settles its Patent Litigation Against Pacific Biosciences More...
• Genomatica, Inc. Announces Successful Litigation Defense More...
• Synchrogenix Opens in Sweden More...
• Roche (RHHBY) Bets on Alzheimer's Drug More...
• FDA Says Unsure if Novartis AG (NVS) MS Pill Caused Deaths More...
• Stiefel Laboratories Receives FDA Approval of Fabior™ Foam, 0.1% More...
• Gilead Sciences, Inc. (GILD)' HIV Quad Pill Wins Backing From FDA Advisers More...
• Biovest International, Inc. to Seek Marketing Approval in the EU for BiovaxID® Personalized Lymphoma Cancer Vaccine More...
• Ventrus Biosciences, Inc. (VTUS) Unveils Positive Results of Its Phase 3 Trial of Diltiazem More...
• Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Phase III Crohn's Disease Trial Meets Primary Endpoints More...
• BioAlliance Pharma: Initiation of ReLive, Phase III Clinical Trial with Livatag® in Primary Liver Cancer More...
• Schwabing Hospital Release: New Phase III Study Confirms: Ginkgo Biloba Special Extract EGb 761® Significantly Improves Cognition and Neuropsychiatric Symptoms in Cognitive Disorders More...
• Eli Lilly and Company (LLY) Oncology to Highlight Final Results for Phase III Study in Most Common Form of Lung Cancer More...
• American Society of Clinical Oncology Preview: Eight Cancer Drugs to Watch at the Big Show More...
• Red Wine Compound Can Combat Alzheimer's, Georgetown University Medical Center Study More...
• High-Fat Diet Lowered Blood Sugar and Improved Blood Lipids in Diabetics,Linköping University Study More...
• Blood Pressure Drugs Don't Protect Against Colorectal Cancer, Cancer Reveals More...
• BG Medicine Announces Publication of First Study on Use of Galectin-3 in Selection of Drug Therapy in Heart Failure More...
• Agenix Limited: New Patent Granted in Japan Enhances Value of Revolutionary New Australian Blood Clot Diagnostic Technology More...
• Helicos BioSciences Corporation (HLCS) Settles its Patent Litigation Against Pacific Biosciences More...
• Biogen Idec, Inc. (Massachusetts) (BIIB)'s New AVONEX® Dosing Innovations for People with Multiple Sclerosis Now Available in US More...
0 comments